Medically reviewed by Dr. Ehtesham Ghani, Internal Medicine & Bariatric Medicine (ASBP). Last reviewed June 2026.
It is one of the most common questions we hear at ThinFast MD: “If these medications work so well, what happens when I stop taking them?” It is a smart question to ask, and the honest answer is that for many people, some weight does come back without a deliberate plan. The good news is that this is not inevitable, and understanding why it happens is the first step to protecting the progress you have worked so hard for. Building a long-term weight-loss maintenance strategy is what separates a temporary result from a lasting one.
Why does weight come back after stopping a GLP-1?
GLP-1 and dual GLP-1/GIP medications such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) work in large part by quieting appetite and slowing how quickly your stomach empties, so you feel full sooner and longer. Used with diet, exercise, and medical supervision, they help reduce the constant “food noise” that drives overeating. When the medication is stopped, those biological signals gradually return to where they were before. Appetite often increases again, and the body’s tendency to defend a higher weight set point can reassert itself. In other words, the medication was managing an underlying condition rather than curing it, much like blood pressure or cholesterol medication. Keep in mind that Ozempic and Mounjaro are FDA-approved to treat type 2 diabetes, and their use for weight loss is off-label.
What do the clinical trials actually show?
Research gives us a clear, sobering picture. In a semaglutide withdrawal extension of the STEP program, participants who stopped the medication regained a substantial portion of the weight they had lost over the following year, while those who continued tended to maintain or keep losing. A similar pattern appeared in SURMOUNT-4, a tirzepatide trial: people who switched to placebo regained much of their lost weight, whereas those who stayed on treatment generally held onto their results.
For context, these medications produce meaningful loss while being taken. Semaglutide showed average reductions of roughly 15% of body weight in STEP trials, and tirzepatide produced averages in the range of about 15% to 21% across SURMOUNT studies, with the head-to-head SURMOUNT-5 trial showing roughly 20% with tirzepatide versus about 14% with semaglutide. Older appetite suppressants like phentermine offer more modest short-term results, often in the range of about 3% to 7%. The key takeaway from the withdrawal data is not that the medications fail, but that stopping abruptly without a maintenance plan tends to undo a meaningful share of the progress. Individual results vary, and these numbers are averages from controlled studies, not promises.
Does everyone regain the weight?
No. The trial averages describe groups, not individuals, and your own outcome depends heavily on what you do during and after treatment. People who use their time on medication to build durable habits, including consistent protein intake, strength training, sleep, and stress management, are often better positioned to hold their results. The medication can be thought of as a window of opportunity: while appetite is easier to manage, it becomes far more realistic to establish the routines that support a lower weight long term. How much you regain, if any, is influenced by genetics, your starting point, how the medication is tapered, and the support system around you.
How can you keep the weight off long term?
Maintenance is an active strategy, not a finish line. At ThinFast MD, our physician-supervised approach focuses on several proven levers:
- A structured maintenance plan rather than an abrupt stop, so your body is not left to readjust without support.
- Possible dose adjustment or a lower maintenance dose for some patients, decided individually with your provider.
- Nutrition counseling to lock in eating patterns that hold results without the medication doing all the work.
- Strength and resistance training to preserve lean muscle, which supports metabolism.
- Regular follow-up so changes are caught early and addressed before they compound.
The decision of whether to continue, taper, or transition off a GLP-1 is a medical one that should be made together with a physician who knows your history. As with any GLP-1 medication, your provider will review relevant safety information, including the boxed warning regarding the risk of thyroid C-cell tumors (MTC) and use in those with a personal or family history of medullary thyroid carcinoma or MEN 2.
What should you do if you are thinking about stopping?
The most important thing is to not stop on your own without a plan. Whether you are pausing because of cost, side effects, supply, or because you have reached your goal, our team can help you map out a transition that protects your results. We tailor maintenance strategies to each patient across our four Illinois locations in Hinsdale, Arlington Heights, Brookfield, and Rockford. If you have questions about what comes after your GLP-1 medication, call ThinFast MD at (708) 485-4050 to schedule a consultation and build a plan designed around your goals.
This article is for educational purposes only and is not medical advice. It is not a substitute for diagnosis or treatment from your physician. Weight-loss results vary from person to person. Always consult a qualified healthcare provider before starting or stopping any medication. In a medical emergency, call 911.
